We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Experts Urge Focus on Resuscitation Research

By HospiMedica staff writers
Posted on 04 Jun 2002
A report from US resuscitation experts states that increased research, education, and funding can improve the treatment of people who experience cardiac arrest. More...
In the United States alone, more than 680 people die each day due to cardiac arrest. The new report was published in the May 28, 2002, issue of Circulation.

Resuscitation research focuses on conditions that initiate, mediate, and result when all of the body's organs are deprived of oxygen. Better methods are needed to lower the risk of injury and restore cardiopulmonary and cerebral function. To accomplish this, the experts recommended a number of steps. These are to develop a national center for resuscitation research, implement programs to support that research, establish a system to promote and coordinate research, establish databases of clinical cases, prioritize new resuscitation strategies, and promote professional and public education and training.

One research priority is hibernation physiology, whereby animals can tolerate ischemia and reperfusion without injury. Animal studies have shown that the heart rate decreases to as little as 5% of normal during hibernation, yet the heart is not damaged during this time. Other research priorities include existing and proposed therapies for cardiac arrest, investigating the potential of hypothermia and controlled reperfusion, developing better experimental models to study cardiac arrest, and developing sensors to detect blood flow restrictions.

"We have an opportunity to prioritize a science that will lead immediately, I think, to saving many, many lives, not only in the United States but worldwide,” said Dr. Lance Becker, lead author of the report and a professor of clinical medicine in the emergency medicine section of the University of Chicago (Il, USA). "We are on the brink of major scientific progress in the field of resuscitation. Investment at this critical point in time will lead to important advances.”




Related Links:
Univ. of Chicago

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.